Gaithersburg, MD, United States of America

Gregory M Glenn

This inventor holds 36 USPTO granted patents and 3 published patent applications and 8 EPO patents, primarily in Biotechnology Innovations. Top assignees: United States of America, as Represented by the Secretary of Agriculture, US Government as Represented by the Secretary of the Army, Valneva Austria Gmbh. Active years: 1991-2025.

USPTO Granted Patents = 36 (Patent Applications = 3)

% Patents Active = 72.2

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 2.8

ph-index = 10

Forward Citations = 365(Granted Patents)

Location History:

Vallejo, CA (US) (1991)
Bethesda, MD (US) (1999 - 2006)
Cabin John, MD (US) (2004 - 2008)
American Canyon, CA (US) (1997 - 2022)
Gaithersburg, MD (US) (2014 - 2022)
Potomac, MD (US) (2022)
Poolesville, MD (US) (2009 - 2024)

Company Filing History:

13 out of 1,214

United States of America, as Represented by the Secretary of Agriculture

patents

6 out of 8,741

US Government as Represented by the Secretary of the Army

The United States of America as Represented by the Secretary of

The United States of America as Represented by the U.S. Army Medical

patent

where one patent can have more than one assignee

Years Active: 1991-2025

Loading Chart...

Areas of Expertise:

Vaccine Compositions

Immune Responses

Biopolymer Additives

Transcutaneous Immunization

Moisture-Resistant Materials

Fiber Reinforced Composites

Biodegradable Compositions

Food Packaging

Starch-Based Materials

Pheromone Release Devices

Abrasive Compositions

Wheat Kernel Classification

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12454795 - Moisture/oil-resistant fiber/starch composite materials (2025-10-28),

2. 12324831 - Isolated polypeptide of the toxin A and toxin B proteins ofand uses thereof (2025-06-10),

3. 12083228 - Methods and compositions for treating respiratory disease (2024-09-10),

4. 11938179 - Methods and compositions for inducing immune responses against (2024-03-26),

5. 11478540 - Isolated polypeptide of the toxin A and toxin B proteins ofand uses thereof (2022-10-25),

6. 11364294 - Vaccine compositions having improved stability and immunogenicity (2022-06-21),

7. 11357844 - Isolated polypeptide of the toxin A and toxin B proteins ofand uses thereof (2022-06-14),

8. 11339275 - Compositions and methods for food packaging (2022-05-24),

9. 11253585 - Vaccine compositions having improved stability and immunogenicity (2022-02-22),

10. 11123419 - Methods and compositions for inducing immune responses against Clostridium difficile (2021-09-21),

11. 10821166 - Isolated polypeptide of the toxin A and toxin B proteins ofand uses thereof (2020-11-03),

12. 10426829 - Vaccine compositions having improved stability and immunogenicity (2019-10-01),

13. 10357557 - Isolated polypeptide of the toxin A and toxin B proteins ofand uses thereof (2019-07-23),

14. 9688933 - Charcoal-foam heating material (2017-06-27),

15. 9598472 - [object Object] (2017-03-21),

Title: Innovator Spotlight: Gregory M Glenn

Introduction: Gregory M Glenn, a prolific inventor based in Gaithersburg, MD, has made significant contributions to the field of biotechnology with a total of 32 patents under his name. His latest inventions showcase his expertise in developing novel solutions for vaccine compositions and toxin neutralization.

Latest Patents: One of Gregory M Glenn's recent patents involves the creation of isolated polypeptides known as C-TAB.G5 and C-TAB.G5.1. These polypeptides contain the receptor binding domains of toxin A and toxin B, which can effectively neutralize their toxic effects. Additionally, he has developed nanoparticles for vaccines that enhance stability and immunogenicity by incorporating antigens from pathogens into a detergent core.

Career Highlights: Gregory M Glenn has worked with prestigious institutions such as the United States of America, represented by the Secretary of Agriculture, and the United States of America, represented by the Secretary of the Army. His innovative research has led to groundbreaking advancements in biotechnology, with a focus on developing vaccines and toxin-neutralizing agents.

Collaborations: Throughout his career, Gregory M Glenn has collaborated with esteemed individuals in the field, including Jing-Hui Tian and Carl R Alving. These collaborations have been essential in advancing his research and bringing cutting-edge solutions to the biotechnology industry.

Conclusion: In conclusion, Gregory M Glenn's dedication to innovation and his remarkable contributions to the field of biotechnology have solidified his reputation as a pioneering inventor. His patents not only showcase his creativity and ingenuity but also highlight his commitment to improving healthcare and public safety through groundbreaking scientific advancements.